10 Companies Have Recalled Metformin Since FDA Warning!
Those ten companies are as follows:
- Amneal Pharmaceuticals
- Akvare (Repackages for Amneal)
- Granules Pharmaceuticals
- Lupin Pharmaceuticals
- Marksans Pharma Limited
- PD-Rx (Repackages for Amneal and Marksans)
- Preferred Pharmaceuticals (Repackages for Marksans)
- Teva Pharmaceuticals
- The Harvard Drug Group (Repackages for Apotex)
Click here to view a full list of recalled Metformin Products.
Carcinogen Found in Popular Diabetes Medication, Metformin
Valisure, an online pharmacy that routinely tests medications before shipping them to customers detected extremely high levels of NDMA, a cancer-causing chemical inside of Metformin, a popular diabetes drug.
Valisure sent the FDA a Citizens Petition on March 2nd, asking the FDA to recall Metformin and conduct an investigation into how it became contaminated.
Two months later in May, the FDA released a statement on their website alerting patients and health care professionals to the fact that impure levels of NDMA had been found in extended-release tablets of Metformin. Click here for the full press release.
It is important to note, however, that the FDA did not find any levels of NDMA in instant-release tablets of Metformin, which is widely known to be the most popular form of Metformin.
The FDA has also asked all manufacturers of Metformin to look into a potential risk for excessive levels of NDMA in their extended-release tablets and to alert the FDA if they find a batch of the medication that fits that description so it does not get released to any U.S. markets.
In late 2019, the FDA announced that it had become aware of NDMA within Metformin products in other countries.
The FDA has maintained the stance that it would continue with ongoing tests of Metformin and other medications, and if they’re alerted to any high levels of NDMA or other impurities, that swift action would be taken from their end.
What We Know About Metformin and NDMA:
- The Food and Drug Administration (FDA) publically announced that the popular type-2 diabetes medication Metformin was now found to contain high levels of a cancer-causing contaminant known as N-Nitrosodimethylamine or NDMA.
- The FDA went on to state that they found high levels of this harmful substance in the extended-release tablets of Metformin and asked for it to be voluntarily recalled nationwide.
- Numerous U.S. health experts have warned people to not abruptly stop taking Metformin as it could have negative impacts.
- There’s no short-term risk involved in taking Metformin, at the moment.
- Human beings should only ingest 96 nanograms per day of NDMA.
- Speak to your primary care physician immediately to make a change in medication.
Have You Been Diagnosed With Cancer After Taking Metformin?
Our Firm Fights to Make Negligent Pharmaceutical Companies Pay Those in Need
Every person in the United States who takes a prescription drug is trusting the medical professionals and the companies that manufacture the drugs with their safety. Unfortunately, more often than not, some medications can turn out to be harmful, worsening health and causing severe, sometimes even fatal, side effects for those who need them most.
Sign Up Below For a Free Attorney Consultation!
Marcari, Russotto, Spencer & Balaban handles a full range of mass tort matters, including cases relating to toxic exposure, dangerous drugs, and defective products. Call us today at (855) 435-7247 or contact us online to schedule a free consultation.
For your convenience, we have offices throughout North Carolina, South Carolina, and Virginia.
Use the form below to sign up for a free attorney consultation. Once we have received it, we will make sure to reach out to you as soon as we possibly can to schedule your free attorney consultation.